Major depressive disorder (MDD) is a chronic and recurrent ... of such MDD patients remit following adequate antidepressant treatment, while most MDD patients suffer from significant core ...
There is limited published data at higher doses and none in the treatment of Major Depressive Disorder (MDD). Methods This open-label, pilot study was designed to investigate the efficacy ...
An increase in the global prevalence and burden of depression has been consistently ... in clinical studies for the treatment of MDD is implicated as a major reason for the failure of clinical ...
Eric Cannon, PharmD, FAMCP, open a discussion surrounding payer considerations relating to the treatment of major depressive disorder (MDD). October 31st 2022EP. 2: MDD Treatment Landscape Expert ...
Treating people in low-income countries for major depressive disorder can also help improve their physical health and household members' wellbeing, demonstrating that mental health treatments can ...
A Multi-center, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder. This is a Phase 2B clinical study ...
de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .
New Delhi: Science has confirmed what common wisdom says — exercise is a potent tool to fight depression. A meta-analysis of 218 randomised controlled trials from across the world to examine the ...